Myocardial interstitial fibrosis in heart failure: biological and translational perspectives

A González, EB Schelbert, J Díez, J Butler - Journal of the American …, 2018 - jacc.org
Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …

Immunomodulation strategies for the successful regeneration of a tissue‐engineered vascular graft

F Zhang, MW King - Advanced Healthcare Materials, 2022 - Wiley Online Library
Cardiovascular disease leads to the highest morbidity worldwide. There is an urgent need to
solve the lack of a viable arterial graft for patients requiring coronary artery bypass surgery …

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the …

DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr… - The Lancet, 2019 - thelancet.com
Summary Background The Synergy between PCI with Taxus and Cardiac Surgery
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …

Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial

DW Park, JM Ahn, H Park, SC Yun, DY Kang, PH Lee… - Circulation, 2020 - Am Heart Assoc
Background: Long-term comparative outcomes after percutaneous coronary intervention
(PCI) with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main …

Persistent racial and sex disparities in outcomes after coronary artery bypass surgery: a retrospective clinical registry review in the drug-eluting stent era

ZO Enumah, JK Canner, D Alejo, DS Warren… - Annals of …, 2020 - journals.lww.com
Objective: The purpose of this study was to assess the temporal trends in 30-day mortality by
race group for patients undergoing coronary artery bypass grafting (CABG) between 2011 …

Everolimus-eluting stents or bypass surgery for multivessel coronary artery disease: extended follow-up outcomes of multicenter randomized controlled BEST trial

JM Ahn, DY Kang, SC Yun, S Ho Hur, HJ Park… - Circulation, 2022 - Am Heart Assoc
Background: Long-term comparative outcomes after percutaneous coronary intervention
(PCI) with everolimus-eluting stents and coronary artery bypass grafting (CABG) are limited …

Synchronous versus staged carotid endarterectomy and coronary artery bypass graft for patients with concomitant severe coronary and carotid artery stenosis: a …

A Tzoumas, S Giannopoulos, P Texakalidis… - Annals of vascular …, 2020 - Elsevier
Background Due to the systemic nature of atherosclerosis, arteries at different sites are
commonly simultaneously affected. As a result, severe coronary artery disease (CAD) …

Sex differences in all-cause mortality in the decade following complex coronary revascularization

H Hara, K Takahashi, D van Klaveren, R Wang… - Journal of the American …, 2020 - jacc.org
Background The poorer prognosis of coronary artery disease in females compared with
males is related mainly to differences in baseline characteristics. In the SYNTAX (Synergy …

Revascularization in patients with left main coronary artery disease and left ventricular dysfunction

S Park, JM Ahn, TO Kim, H Park, DY Kang… - Journal of the American …, 2020 - jacc.org
Background Left main coronary artery (LMCA) disease is associated with high mortality and
morbidity due to a large area of jeopardized myocardium. However, the optimal …

miRNA‐200c‐3p promotes endothelial to mesenchymal transition and neointimal hyperplasia in artery bypass grafts

D Chen, C Zhang, J Chen, M Yang… - The Journal of …, 2021 - Wiley Online Library
Increasing evidence has suggested a critical role for endothelial‐to‐mesenchymal transition
(EndoMT) in a variety of pathological conditions. MicroRNA‐200c‐3p (miR‐200c‐3p) has …